Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00664131 · ClinicalTrials.gov registry record
Neurologic Morbidity and Disability in Acute Lymphoblastic Leukemia Survivors
A clinical trial, sponsored by St. Jude Children's Research Hospital.
- Completed
- Registry status
- 165
- Enrollment target
NCT00664131: Completed study, sponsored by St. Jude Children's Research Hospital.
NCT00664131 is a clinical trial that has completed, run by St. Jude Children's Research Hospital. The registered enrollment target is 165 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00664131 has completed, sponsored by St. Jude Children's Research Hospital.
- COMPLETED
- Registry status
- 165 participants
- Enrollment target
Study Summary
Treatment of acute lymphoblastic leukemia achieves high cure rate, but is potentially neurotoxic. Long-term neurologic morbidity in survivors and its effect on function are inadequately studied. Neurologic outcomes will be assessed through an investigator administered questionnaire followed by comprehensive neurologic examination by the study neurologist.
Interventions
- OTHER Neurological Examination/Questionnaires
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 165 participants |
| Start Date | 2005-08 |
| Est. Completion | 2008-10 |
What the finished NCT00664131 record still lists
NCT00664131 is an observational study that tracks outcomes without assigning an intervention. The registered 165 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which Neurological Examination/Questionnaires is the first listed.
NCT00664131 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00664131 about?
NCT00664131 is a clinical study titled "Neurologic Morbidity and Disability in Acute Lymphoblastic Leukemia Survivors". Treatment of acute lymphoblastic leukemia achieves high cure rate, but is potentially neurotoxic. Long-term neurologic morbidity in survivors and its effect on function are inadequately studied. Neurologic outcomes will be assessed through an investigator administered questionnaire followed by com...
What is the current status of trial NCT00664131?
This trial is currently completed. The enrollment target is 165 participants. The study started on 2005-08. Estimated completion is 2008-10.
What interventions are being tested in trial NCT00664131?
The interventions under investigation include: Neurological Examination/Questionnaires (OTHER).
Who is sponsoring clinical trial NCT00664131?
This trial is sponsored by St. Jude Children's Research Hospital, which has 410 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02387255 · 165 participants
Magnetic Resonance Elastography in Patients With Abdominal Aortic Aneurysms
- NCT03351348 · 165 participants · Phase 3
Bupivacaine vs Placebo for Unilateral Mastectomy Surgical Site Post-operative Pain Control
- NCT03830320 · 165 participants · Phase 1
Positron Emission Tomography (PET) Imaging of Thrombosis
- NCT04289571 · 165 participants · Phase 1
Virtual Reality Mobility Assessment of Functional Vision in Retinal Disease
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia